WO2003075852A3 - Antibiotic composition - Google Patents
Antibiotic composition Download PDFInfo
- Publication number
- WO2003075852A3 WO2003075852A3 PCT/US2003/007118 US0307118W WO03075852A3 WO 2003075852 A3 WO2003075852 A3 WO 2003075852A3 US 0307118 W US0307118 W US 0307118W WO 03075852 A3 WO03075852 A3 WO 03075852A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antibiotic composition
- antibiotic
- products
- different
- antibiotics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003574128A JP2005526059A (en) | 2002-03-07 | 2003-03-07 | Antibiotic composition |
AU2003218024A AU2003218024C1 (en) | 2002-03-07 | 2003-03-07 | Antibiotic composition |
EP03714005A EP1487414A4 (en) | 2002-03-07 | 2003-03-07 | Antibiotic composition |
CA002478121A CA2478121A1 (en) | 2002-03-07 | 2003-03-07 | Antibiotic composition |
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/092,811 | 2002-03-07 | ||
US10/092,854 | 2002-03-07 | ||
US10/092,811 US6623758B2 (en) | 2000-02-24 | 2002-03-07 | Cephalosporin-metronidazole antibiotic composition |
US10/092,858 | 2002-03-07 | ||
US10/093,321 US6610328B2 (en) | 2000-02-24 | 2002-03-07 | Amoxicillin-clarithromycin antibiotic composition |
US10/092,858 US6632453B2 (en) | 2000-02-24 | 2002-03-07 | Ciprofoxacin-metronidazole antibiotic composition |
US10/092,854 US6627222B2 (en) | 2000-02-24 | 2002-03-07 | Amoxicillin-dicloxacillin antibiotic composition |
US10/093,214 | 2002-03-07 | ||
US10/093,321 | 2002-03-07 | ||
US10/093,214 US6638532B2 (en) | 2000-02-24 | 2002-03-07 | Tetracycline—doxycycline antibiotic composition |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003075852A2 WO2003075852A2 (en) | 2003-09-18 |
WO2003075852A3 true WO2003075852A3 (en) | 2004-07-15 |
Family
ID=27808882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/007118 WO2003075852A2 (en) | 2002-03-07 | 2003-03-07 | Antibiotic composition |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1487414A4 (en) |
JP (1) | JP2005526059A (en) |
CA (1) | CA2478121A1 (en) |
WO (1) | WO2003075852A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8889187B2 (en) | 2000-02-24 | 2014-11-18 | Shionogi Inc. | Once a day amoxicillin product comprising immediate and delayed release dosage forms |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
AUPS167602A0 (en) * | 2002-04-12 | 2002-05-16 | F.H. Faulding & Co. Limited | An improved modified release preparation |
WO2006014427A1 (en) * | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
MX2007012763A (en) * | 2005-04-12 | 2008-01-14 | Elan Pharma Int Ltd | Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection. |
PT1883396E (en) | 2005-05-18 | 2013-10-08 | Centre Nat Rech Scient | Colonic delivery of adsorbents |
US8048413B2 (en) | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
SI2294012T1 (en) * | 2008-05-07 | 2014-11-28 | Salix Pharmaceuticals, Ltd. | Administration of a bowel cleanser and an antibiotic for the treatment of bowel disease |
US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4794001A (en) * | 1986-03-04 | 1988-12-27 | American Home Products Corporation | Formulations providing three distinct releases |
US5001692A (en) * | 1987-04-21 | 1991-03-19 | U.S. Philips Corporation | Optical recording system providing a recording signal waveform adapted to the recording characteristics of the record carrier, and recording apparatus and record carrier for use in such systems |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS601128A (en) * | 1983-06-15 | 1985-01-07 | Shionogi & Co Ltd | Long-acting cefaclor preparation |
JPS61210025A (en) * | 1985-03-14 | 1986-09-18 | Teisan Seiyaku Kk | Stabilized antibioitc complex granule preparation |
US4728512A (en) * | 1985-05-06 | 1988-03-01 | American Home Products Corporation | Formulations providing three distinct releases |
JPS63162619A (en) * | 1986-12-25 | 1988-07-06 | Teisan Seiyaku Kk | Delayed soluble granule and sustained release complex granule using said granule |
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
US5260068A (en) * | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
US5260069A (en) * | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
AU7966694A (en) * | 1993-07-21 | 1996-05-02 | University Of Kentucky Research Foundation, The | A multicompartment hard capsule with control release properties |
DE19718012C1 (en) * | 1997-04-29 | 1998-10-08 | Jenapharm Gmbh | Process for the production of orally applicable solid pharmaceutical forms with controlled release of active substances |
US5840329A (en) * | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
AUPP437698A0 (en) * | 1998-06-30 | 1998-07-23 | Baumgart, Karl | Methods for treatment of coronary, carotid and other vascular disease |
US6384081B2 (en) * | 1998-10-09 | 2002-05-07 | Charles L. Berman | Treatment of diseases of the eye characterized by the formation of metalloproteinase |
US6544555B2 (en) * | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6623757B2 (en) * | 2000-02-24 | 2003-09-23 | Advancis Pharmaceutical Corp. | Antibiotic composition |
US6565882B2 (en) * | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
-
2003
- 2003-03-07 CA CA002478121A patent/CA2478121A1/en not_active Abandoned
- 2003-03-07 WO PCT/US2003/007118 patent/WO2003075852A2/en active Application Filing
- 2003-03-07 EP EP03714005A patent/EP1487414A4/en not_active Withdrawn
- 2003-03-07 JP JP2003574128A patent/JP2005526059A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4794001A (en) * | 1986-03-04 | 1988-12-27 | American Home Products Corporation | Formulations providing three distinct releases |
US5001692A (en) * | 1987-04-21 | 1991-03-19 | U.S. Philips Corporation | Optical recording system providing a recording signal waveform adapted to the recording characteristics of the record carrier, and recording apparatus and record carrier for use in such systems |
Non-Patent Citations (1)
Title |
---|
See also references of EP1487414A4 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8889187B2 (en) | 2000-02-24 | 2014-11-18 | Shionogi Inc. | Once a day amoxicillin product comprising immediate and delayed release dosage forms |
Also Published As
Publication number | Publication date |
---|---|
AU2003218024A1 (en) | 2003-09-22 |
EP1487414A4 (en) | 2007-12-12 |
WO2003075852A2 (en) | 2003-09-18 |
AU2003218024B2 (en) | 2008-09-11 |
EP1487414A2 (en) | 2004-12-22 |
CA2478121A1 (en) | 2003-09-18 |
JP2005526059A (en) | 2005-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004103311A3 (en) | Antibiotic composition | |
CA2400818A1 (en) | Antibiotic and antifungal compositions | |
AU2003289641A1 (en) | The novel coumarin-amide derivatives and its preparation, said drug composition and its use | |
IL165977A (en) | Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same | |
IL182121A0 (en) | Pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containingthe same | |
AU2003228666A1 (en) | Lapachone delivery systems, compositions and uses related thereto | |
AU2003247798A1 (en) | Nozzles and components thereof and methods for making the same | |
IL211281A (en) | [1,2,4]triazolo [4,3-a]pyridine derivatives and pharmaceutical compositions comprising the same | |
HK1167332A1 (en) | Pharmaceutical composition, use thereof and method for making the same | |
ZA200500877B (en) | Antimicrobial aza-bicyclic derivatives, their compositions and uses. | |
EP1831240B8 (en) | 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same | |
WO2003011226A3 (en) | Products and drug delivery vehicles | |
AU2002319320A1 (en) | Substituted isoxazoles and the use thereof as antibiotics | |
EP1542656A4 (en) | Antibiotic product, use and formulation thereof | |
ZA200410211B (en) | Quinuclidine derivatives and pharmaceutical compositions containing the same. | |
AU2002228317A1 (en) | Benz-1,3-azole derivatives and their uses as heparanase inhibitors | |
WO2003075852A3 (en) | Antibiotic composition | |
ZA200305040B (en) | Pharmaceutical compositions with antibiotic activity. | |
WO2003047589A8 (en) | Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission | |
WO2005009368A3 (en) | Antibiotic product, use and formulation thereof | |
WO2005009365A3 (en) | Antibiotic product, use and formulation thereof | |
EP4219459A4 (en) | 1h-pyrrolo[2,3-c]pyridine compounds and application thereof | |
WO2005009364A3 (en) | Antibiotic product, use and formulation thereof | |
AU2002333910A1 (en) | Pharmaceutical composition for the treatment of viral, fungal and bacterial infections and applications of same | |
WO2003090674A3 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2478121 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003218024 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003574128 Country of ref document: JP |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003714005 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003714005 Country of ref document: EP |